KMB vs KO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Kimberly-Clark (KMB) trades at a significant discount to its 52-week high ($150.45) with a 1Y return of -18.0%, reflecting persistent macro and operational headwinds. While the stock offers a compelling 4.85% dividend yield and is attractively valued on forward P/E (13.63x vs sector avg 23.76x), near-term earnings growth is deeply negative (YoY EPS -50.2%), and profitability has eroded amid inflationary cost pressures. The company’s high leverage (Debt/Equity: 5.00) and weak liquidity (Current Ratio: 0.77) raise structural concerns, though recent quarterly earnings surprises have trended positive. Analysts maintain a 'hold' rating with a $128.62 target, implying ~23.6% upside, but insider selling and stagnant revenue growth temper conviction.
KO exhibits a significant disconnect between its current market price ($75.44) and its deterministic value markers, with a Piotroski F-Score of 3/9 indicating weak financial health trends. The stock trades at a massive premium to both its Graham Number ($22.43) and Intrinsic Value ($37.08), while a PEG ratio of 3.95 suggests severe overvaluation relative to its stagnant growth. Despite strong historical earnings beats and high ROE, the combination of bearish insider selling and a 0/100 technical trend signals a lack of immediate catalyst for upside.
Compare Another Pair
Related Comparisons
KMB vs KO: Head-to-Head Comparison
This page compares Kimberly-Clark Corporation (KMB) and The Coca-Cola Company (KO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.